Collection of Blood From Patients With Pancytopenia
NCT00001214 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38
Last updated 2020-08-21
Summary
Aplastic anemia is a condition in which the cells normally found in blood are greatly decreased. The normal levels of white blood cells, red blood cells, and platelets are much lower in patients with aplastic anemia.
Because of these low levels of blood cells, patients with aplastic anemia have a variety of immune system abnormalities. However, low levels of blood cells make it difficult to collect specialized white blood cells (mononuclear cells) for research studies.
This study was designed to collect lymphocytes from patients with low levels of all blood cells (pancytopenia) for use in research. Patients participating in the study will undergo a special procedure known as lymphapheresis. During lymphapheresis blood is taken from the patient in a manner similar to blood donation. The white blood cells are selectively removed by spinning (centrifugation), and the remaining red blood cells and platelets are placed back (re-infused) into the donor s blood stream.
Patients participating in this study will not benefit directly from it. However, cells collected in this study may increase scientific knowledge and improve understanding and treatment for diseases like aplastic anemia.
Conditions
- Pancytopenia
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Neal S Young, M.D. · National Heart, Lung, and Blood Institute (NHLBI)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1986-04-30
- Primary Completion
- 2009-01-19
- Completion
- 2020-08-17
Countries
- United States
Study Locations
More Related Trials
-
Extended Dosing With Eltrombopag for Severe Aplastic Anemia
NCT01891994 ·Status: COMPLETED ·Phase: PHASE2
-
Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study
NCT06991894 ·Status: COMPLETED
-
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients
NCT00922883 ·Status: COMPLETED ·Phase: PHASE2
-
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
NCT01623167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Bleeding In Thrombocytopenia Explained
NCT03505086 ·Status: RECRUITING
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
Eltrombopag & Cyclosporine in Children With Sever Aplastic Anemia
NCT03243656 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia
NCT02148133 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
NCT06254560 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
NCT01703169 ·Status: COMPLETED ·Phase: PHASE2
-
Biologic Characterization of Patients With ITP
NCT05694325 ·Status: RECRUITING ·Phase: NA
-
Value of Platelet Indices as Predictive Factor in Thrombocytopenia
NCT05116033 ·Status: UNKNOWN
-
Haploidentical Transplantation in Severe Aplastic Anemia
NCT03246178 ·Status: UNKNOWN ·Phase: NA
-
Avatrombopag Combined With IST as First-line Treatment for SAA
NCT05720234 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis
NCT01149681 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia
NCT04870346 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
NCT05018936 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT
NCT01286675 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)
NCT02773225 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Trial to Reduce Alloimmunization to Platelets (TRAP)
NCT00000589 ·Status: COMPLETED ·Phase: PHASE3
-
AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
NCT02218047 ·Status: COMPLETED ·Phase: PHASE3
-
Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
NCT02298075 ·Status: COMPLETED
-
Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic Anemia
NCT07297550 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia
NCT05832216 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure
NCT02912884 ·Status: COMPLETED